Barriers and facilitators to safer supply pilot program implementation in Canada: a qualitative assessment of service provider perspectives.

ABSTRACT:

Background

In response to the ongoing drug toxicity crisis, driven by fentanyl and its analogues in the unregulated drug supply, Canada has funded several safer supply programs, which provide pharmaceutical-grade medications to reduce the reliance on toxic unregulated drug supply for people who use drugs. In this study, we examined barriers and facilitators that influenced the implementation of integrated safer supply pilot programs (ISSPP) across Canada.

Methods

Between March 2022 and May 2023, we conducted a qualitative study using semi-structured interviews with key informants from ten ISSPP located in three provinces across Canada. Data analysis and interpretation of findings were guided by the Consolidated Framework for Implementation Research (CFIR). Thematic analysis

SUBMITTER: Nafeh F 

PROVIDER: S-EPMC12039088 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature